Phase 2 Clinical Trial to Optimize Immune Coverage of SARS-CoV-2 Existing and Emerging Variants (short title, COVID-19 Adaptive Variant Immunologic Landscape Trial (COVAIL Trial)

Project: Other project

Project Details

StatusActive
Effective start/end date3/31/22 → 12/31/23

Funding

  • Leidos Biomedical Research Inc: $305,437.50